RNAmed – a new graduate program of the Elitenetzwerk Bayern
ISAR Bioscience is part of the doctoral program “RNAmed”, which is funded by the Elite Network Bavaria. Eleven university research teams from Würzburg, Regensburg and Munich will cooperate with ISAR Bioscience as an industrial partner. The goal of the program is to train doctoral students in the new research field of RNA-based medicine.
RNA-based agents have achieved a high profile as novel corona vaccines. However, their importance goes far beyond that: RNA-based therapeutics have been developed for several diseases in recent years. In principle, it is conceivable to use novel RNA drugs to switch off or on any protein in the human body and, moreover, to interfere with the diverse regulatory mechanisms of various RNAs. Meanwhile, it is becoming increasingly clear that RNA is poised to become another important class of molecules for the diagnosis, prevention and treatment of disease.
RNAmed takes a holistic approach to equip PhD students with the necessary knowledge and skills in the rapidly growing field of RNA-based medicine. We are currently training a group of international PhD students who will work in this exciting research area and advance precision medicine and targeted molecular therapies. The international and interdisciplinary nature, diverse networking, extra-curricular activities and the goal of pharmaceutical-pharmacological translation are key features of RNAmed. The program is scheduled to begin in December 2022.